Education
About Us
Working with TipRanks
Follow Us
Agilon Health (AGL)
NYSE:AGL
AGL Analyst Ratings
Hold
2 Buy
9 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AGL Stock 12 Month Forecast
Average Price Target
$1.21
▲(0.00% Upside)
| Highest Price Target$1.50 | Average Price Target$1.21 | Lowest Price Target$1.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bernstein
$4→$1.4
Hold
15.70%
Upside
Downgraded
08/20/25
Jefferies
$2.4→$1.1
Hold
-9.09%
Downside
Reiterated
08/15/25
Robert W. Baird
$5→$1
Hold
-17.36%
Downside
Reiterated
08/14/25
Truist Financial
―
Hold
―
Reiterated
08/14/25
Benchmark Co.
$4→$1.5
Buy
23.97%
Upside
Reiterated
08/06/25
TD Cowen
$4→$1
Hold
-17.36%
Downside
Reiterated
08/06/25
Bank of America Securities
$2.4→$1.3
Sell
7.44%
Upside
Reiterated
08/05/25
Leerink Partners
$4.5→$1.5
Hold
23.97%
Upside
Reiterated
08/05/25
Needham
―
Hold
―
Reiterated
08/05/25
Agilon Health's Hold Rating Amid CEO Resignation and Earnings ShortfallWe reiterate Hold on AGL following a surprise earnings announcement that came a day ahead of schedule due to the resignation of President and CEO Steven Sell. Q2 results also came in below expectations due to negative prior period developments and overestimated risk adjustment revenue, which in conjunction with the management change, led the company to withdraw its FY25 guidance. While turnaround efforts appeared to be bearing fruit in Q1, visibility around the business has again reversed, making it incrementally difficult to gauge the success of strategic initiatives at this point of the year. As such, we continue to view 2H25 and into 2026 as a "show me" time for the company, and fear shares will remain range bound until the reinstatement of guidance, keeping us sidelined for the time being.
Evercore ISI
$5→$1
Hold
-17.36%
Downside
Reiterated
08/05/25
Barclays
$3→$1.5
Sell
23.97%
Upside
Reiterated
08/05/25
William Blair
―
Hold
―
Reiterated
08/04/25
Wells Fargo
$6→$5
Buy
313.22%
Upside
Reiterated
05/12/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bernstein
$4→$1.4
Hold
15.70%
Upside
Downgraded
08/20/25
Jefferies
$2.4→$1.1
Hold
-9.09%
Downside
Reiterated
08/15/25
Robert W. Baird
$5→$1
Hold
-17.36%
Downside
Reiterated
08/14/25
Truist Financial
―
Hold
―
Reiterated
08/14/25
Benchmark Co.
$4→$1.5
Buy
23.97%
Upside
Reiterated
08/06/25
TD Cowen
$4→$1
Hold
-17.36%
Downside
Reiterated
08/06/25
Bank of America Securities
$2.4→$1.3
Sell
7.44%
Upside
Reiterated
08/05/25
Leerink Partners
$4.5→$1.5
Hold
23.97%
Upside
Reiterated
08/05/25
Needham
―
Hold
―
Reiterated
08/05/25
Agilon Health's Hold Rating Amid CEO Resignation and Earnings ShortfallWe reiterate Hold on AGL following a surprise earnings announcement that came a day ahead of schedule due to the resignation of President and CEO Steven Sell. Q2 results also came in below expectations due to negative prior period developments and overestimated risk adjustment revenue, which in conjunction with the management change, led the company to withdraw its FY25 guidance. While turnaround efforts appeared to be bearing fruit in Q1, visibility around the business has again reversed, making it incrementally difficult to gauge the success of strategic initiatives at this point of the year. As such, we continue to view 2H25 and into 2026 as a "show me" time for the company, and fear shares will remain range bound until the reinstatement of guidance, keeping us sidelined for the time being.
Evercore ISI
$5→$1
Hold
-17.36%
Downside
Reiterated
08/05/25
Barclays
$3→$1.5
Sell
23.97%
Upside
Reiterated
08/05/25
William Blair
―
Hold
―
Reiterated
08/04/25
Wells Fargo
$6→$5
Buy
313.22%
Upside
Reiterated
05/12/25
Best Analysts Covering Agilon Health
1 Month
xxx
Success Rate
9/21 ratings generated profit
Average Return
-1.60%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of -1.60% per trade.
3 Months
xxx
Success Rate
5/14 ratings generated profit
Average Return
-2.77%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 35.71% of your transactions generating a profit, with an average return of -2.77% per trade.
1 Year
Success Rate
0/14 ratings generated profit
Average Return
-57.22%
reiterated a buy rating 6 months ago
Copying Sean Dodge's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -57.22% per trade.
2 Years
xxx
Success Rate
0/21 ratings generated profit
Average Return
-72.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -72.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AGL Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
2
4
6
7
6
Buy
6
4
3
1
1
Hold
23
23
20
20
22
Sell
2
2
2
2
3
Strong Sell
0
0
0
0
0
total
33
33
31
30
32
Each month's total comprises the sum of three months' worth of ratings.
AGL Financial Forecast
AGL Stock Forecast FAQ
What is AGL’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilon Health’s 12-month average price target is 1.21.
What is AGL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AGL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AGL a Buy, Sell or Hold?
Agilon Health has a consensus rating of Hold which is based on 2 buy ratings, 9 hold ratings and 2 sell ratings.
What is Agilon Health’s price target?
The average price target for Agilon Health is 1.21. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.50 ,the lowest forecast is $1.00. The average price target represents 0.00% Increase from the current price of $1.21.
The highest analyst price target is $1.50 ,the lowest forecast is $1.00. The average price target represents 0.00% Increase from the current price of $1.21.
What do analysts say about Agilon Health?
Agilon Health’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of AGL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.